Related Experiment Videos
[18F]haloperidol binding in baboon brain in vivo
K A Yousef1, J S Fowler, N D Volkow
1Chemistry Department, Brookhaven National Laboratory, Upton, NY 11973, USA.
Nuclear Medicine and Biology
|January 1, 1996
Summary
[18F]haloperidol binding in baboon brains did not selectively target dopamine D2 or sigma sites. Positron emission tomography (PET) studies showed widespread binding, unaffected by sigma site blockers but influenced by dopamine D2 receptor ligands.
Area of Science:
- Neuroscience
- Radiochemistry
- Pharmacology
Background:
- Dopamine D2 receptors and sigma sites are crucial targets in neuroscience.
- [18F]haloperidol is a radiotracer used in Positron Emission Tomography (PET) imaging.
- Selective imaging of these sites is important for understanding neurological disorders.
Purpose of the Study:
- To investigate the binding characteristics of [18F]haloperidol in baboon brain.
- To determine if [18F]haloperidol can selectively image dopamine D2 or sigma sites using PET.
- To assess the impact of specific receptor ligands on tracer binding.
Main Methods:
- Positron Emission Tomography (PET) imaging in baboon subjects.
- Administration of [18F]haloperidol at baseline and after drug treatments.
- Use of haloperidol, (+)-butaclamol (dopamine D2 specific), and (-)-butaclamol (sigma site specific).
Main Results:
- [18F]haloperidol exhibited widespread binding throughout the baboon brain.
- (+)-butaclamol selectively reduced tracer uptake in the striatum, indicating dopamine D2 receptor interaction.
- (-)-butaclamol showed no significant effect on [18F]haloperidol binding.
- Haloperidol treatment accelerated tracer clearance from brain regions.
Conclusions:
- The binding profile of [18F]haloperidol is not selective for either dopamine D2 or sigma sites.
- PET imaging with [18F]haloperidol cannot differentiate between these two binding targets.
- Further development of selective radiotracers is needed for targeted imaging.